Literature DB >> 8000528

An investigation of plasmids from Staphylococcus aureus that mediate resistance to mupirocin and tetracycline.

C Needham1, M Rahman, K G Dyke, W C Noble.   

Abstract

Plasmids conferring mupirocin resistance were prepared from isolates of Staphylococcus aureus obtained from four patients in the same ward. The plasmids are related and in all of them the gene conferring mupirocin resistance (mupA) is flanked by copies of IS257 in direct repeat. In two plasmids mupA and IS257 have been duplicated and in one of these plasmids (pJ3358) a small pT181-like plasmid conferring tetracycline resistance is present flanked by copies of IS257. Filter mating with a strain containing pJ3358 as donor and selection on tetracycline sometimes resulted in transfer of the pT181-like plasmid containing a copy of IS257. Analysis showed that the pT181-like plasmid with the insertion of IS257 is present in high copy number and that the IS257 element is inserted in the copy number control region of the plasmid.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8000528     DOI: 10.1099/00221287-140-10-2577

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  10 in total

1.  An IS257-derived hybrid promoter directs transcription of a tetA(K) tetracycline resistance gene in the Staphylococcus aureus chromosomal mec region.

Authors:  A E Simpson; R A Skurray; N Firth
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

2.  High-level mupirocin resistance within methicillin-resistant Staphylococcus aureus pandemic lineages.

Authors:  Eduardo Pérez-Roth; Celeste López-Aguilar; Julia Alcoba-Florez; Sebastián Méndez-Alvarez
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

Review 3.  Current and Emerging Topical Antibacterials and Antiseptics: Agents, Action, and Resistance Patterns.

Authors:  Deborah A Williamson; Glen P Carter; Benjamin P Howden
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

4.  Conjugative transfer of high-level mupirocin resistance from Staphylococcus haemolyticus to other staphylococci.

Authors:  E E Udo; L E Jacob; E M Mokadas
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

5.  Emergence of high-level mupirocin resistance in coagulase-negative staphylococci associated with increased short-term mupirocin use.

Authors:  Erik Bathoorn; David J Hetem; Jeriela Alphenaar; Johannes G Kusters; Marc J M Bonten
Journal:  J Clin Microbiol       Date:  2012-07-03       Impact factor: 5.948

6.  Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance.

Authors:  I Chopra; M Roberts
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

7.  Integration of pT181-like tetracycline resistance plasmids into large staphylococcal plasmids involves IS257.

Authors:  C Werckenthin; S Schwarz; M C Roberts
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

8.  Molecular diversity and characterization of tetracycline-resistant Staphylococcus aureus isolates from a poultry processing plant.

Authors:  Geert Huys; Klaas D'Haene; Johan Van Eldere; Alexander von Holy; Jean Swings
Journal:  Appl Environ Microbiol       Date:  2005-01       Impact factor: 4.792

9.  Phenotypic and molecular characterization of Staphylococcus aureus isolates expressing low- and high-level mupirocin resistance in Nigeria and South Africa.

Authors:  Adebayo O Shittu; Edet E Udo; Johnson Lin
Journal:  BMC Infect Dis       Date:  2009-01-28       Impact factor: 3.090

10.  Dissemination of Novel Antimicrobial Resistance Mechanisms through the Insertion Sequence Mediated Spread of Metabolic Genes.

Authors:  Leonardo Furi; Richard Haigh; Zaaima J H Al Jabri; Ian Morrissey; Hong-Yu Ou; Ricardo León-Sampedro; Jose L Martinez; Teresa M Coque; Marco R Oggioni
Journal:  Front Microbiol       Date:  2016-06-28       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.